Silverback Therapeutics Raises $85 Million in Series C Financing; Company Announces Executive Promotions
Amount Raised
$85 Million
Round Type
Series C
LausanneBiotechnologyHealth CareTherapeuticsDescription
Silverback Therapeutics, Inc. (“Silverback”) (“the Company”), a clinical-stage biopharmaceutical company leveraging its proprietary ImmunoTAC technology platform to develop systemically delivered and tissue-targeted therapeutics for the treatment of cancer and other serious diseases, today announced the close of an $85 million Series C financing round. EcoR1 Capital led the round, with participation from new investors including Boxer Capital of Tavistock Group, Fidelity Management & Research Company LLC, Nantahala Capital Management, and RA Capital. Existing investors also participating in the financing included OrbiMed Advisors, U.S
Quick answer
Asceneuron raised $85 Million in a Series C round, dated September 23, 2020. Asceneuron is based in Lausanne, Vaud, Switzerland.
- How much did Asceneuron raise?
- Asceneuron raised $85 Million in a Series C round on September 23, 2020.
- What does Asceneuron do?
- Asceneuron is a clinical stage biotech company focused on the development of orally bioavailable therapeutics for debilitating neurodegenerative disorders with high unmet medical need.
- Where is Asceneuron based and how big is it?
- Asceneuron is based in Lausanne, Vaud, Switzerland.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Asceneuron that raised within 45 days of this round, from Fundz verified event records.
- Viridian Therapeutics raised $91M on November 6, 2020.
- Damora Therapeutics, Inc. raised $64M on November 5, 2020.
- Strata Oncology raised $5M on November 4, 2020.
- Lipella Pharmaceuticals raised $405K (Seed) on November 4, 2020.
- AbSci Corp raised $65M on October 30, 2020.
- Q32 Bio raised $60M (Series B) on October 29, 2020.
Who to call at Asceneuron, and when
A new round usually means Asceneuron is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Asceneuron raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Asceneuron, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Asceneuron. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Asceneuron raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Asceneuron raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.